Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

• Hoofdauteurs: Maria Rosario Z. Capeding (Auteur), Maria Liza Antoinette M. Gonzales (Auteur), Mandeep Singh Dhingra (Auteur), Naveena Aloysia D'Cor (Auteur), Venkat Jayanth Midde (Auteur), Badri Narayan Patnaik (Auteur), Yaël Thollot (Auteur), Eric Desauziers (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2017-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The killed bivalent (O1 and O139) whole cell oral cholera vaccine (OCV) (Shanchol™) was first licensed in India in 2009 and World Health Organization pre-qualified in 2011. We assessed the safety and immunogenicity of this OCV in the Philippines. This was a phase IV, single-arm, descriptive, open-la...